Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

OBJECTIVE: A large‐scale, double‐blind trial (SP0993; NCT01243177) demonstrated that lacosamide was noninferior to controlled‐release carbamazepine (carbamazepine‐CR) in terms of efficacy, and well tolerated as first‐line monotherapy in patients (≥16 years of age) with newly diagnosed epilepsy. We r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Epilepsia
Hlavní autoři: Ben‐Menachem, Elinor, Grebe, Hans Peter, Terada, Kiyohito, Jensen, Lori, Li, Ting, De Backer, Marc, Steiniger‐Brach, Björn, Gasalla, Teresa, Brock, Melissa, Biton, Victor
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Full‐length Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988520/
https://ncbi.nlm.nih.gov/pubmed/31755090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16381
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky